28

Clinical Trials

Medicenna recognizes that patient participation in clinical trials is critical in order to advance treatment for cancer and is developing its lead product MDNA55 in the clinic for cancers that have a significant unmet medical need. MDNA55 is currently being studied in clinical trials for treatment of CNS cancers.

Phase 2 Clinical Trial Open to Enrollment

In April 2017 Medicenna announced that it had treated the first patient in its Phase 2 trial of MDNA55 in adults with recurrent Glioblastoma where MDNA55 is administered intratumorally using one infusion.

Find Open Clinical Trials

For more information about this study, including study design, eligibility criteria and up to date contact information for the participating hospitals please visit trial record (NCT02858895) on clinicaltrials.gov. You can also search clinicaltrials.gov to find out if other clinical trials exist for a specific medicine for a particular disease.

Hospitals Participating In This Clinical Trial Include:

California
University of California San Francisco
San Francisco, California,
United States, 94143
Recruiting

Contact: Thelma Munoz, Thelma.Munoz@ucsf.edu
Phone: 415-353-2523
Principal Investigator: Nicholas Butowski, MD

John Wayne Cancer Institute at Providence Saint John’s Health Center
Santa Monica, California,
United States, 90404
Recruiting

Contact: Naj Boucher, Najee.Boucher@providence.org
Phone: 310-582-7460
Principal Investigator: Achal Achrol, MD

Florida
Marcus Neuroscience Institute at Boca Raton Regional Hospital
Boca Raton, Florida,
United States, 33486
Recruiting

Contact: Pilar Zuniga, MD, PZuniga@brrh.com
Phone: 561-955-4800
Principal Investigator: Frank Vrionis, MD

New York
Weill Cornell – New York Presbyterian Hospital
New York, New York,
United States, 10022
Recruiting

Contact: Mary O’Hehir, MAO2037@med.cornell.edu
Phone: 212-746-7373

Contact: Alyson Hignight, ALH3031@med.cornell.edu
Phone: 212-746-1788
Principal Investigator: Mark Souweidane, MD

North Carolina
Duke University Medical Center
Durham, North Carolina,
United States, 27710
Recruiting

Contact: Brain Tumor Center
Phone: 919-684-5301
Principal Investigator: Dina Randazzo, MD

Ohio
Cleveland Clinic
Cleveland, Ohio,
United States, 44195
Recruiting

Contact: Cathy Brewer,RN, brewerc1@ccf.org
Phone: 216-444-0437
Principal Investigator: Michael Vogelbaum, MD, PhD

Oregon
Oregon Health and Science University
Portland, Oregon,
United States, 97239
Recruiting

Contact: Amanda Cole, coleam@ohsu.edu
Phone: 503-494-4988
Principal Investigator: Seunggu Han, MD

Pennsylvania
Hospital of the University of Pennsylvania Health System
Philadelphia, Pennsylvania,
United States, 19104
Recruiting

Contact: Scott Levy, scott.lev@uphs.upenn.edu
Phone: 215-662-6832
Principal Investigator: Steven Brem, MD

Texas
Cancer Therapy and Research Center At The University of Texas Health Science Center At San Antonio
San Antonio, Texas,
United States, 78229
Recruiting

Contact: Epp Goodwin, CTRC-ReferralCenter@uthscsa.edu
Phone: 210-450-5789
Principal Investigator: Andrew Brenner, MD